Showing results (131-140 of 253) with videos related to
Sort By:
Pageof 26
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 31, 2012
Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney diseaseStine E Nielsen, Katrine J Schjoedt, Kasper Rossing, et al.Journal of Diabetes and Its Complications|December 15, 2015
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuriaBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.Cardiovascular Diabetology|March 7, 2012
NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patientsHenrik Reinhard, Peter R Hansen, Niels Wiinberg, et al.Diabetologia|July 7, 2017
Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.Journal of Translational Medicine|July 6, 2016
Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitusMichelle J Pena, Andreas Heinzel, Peter Rossing, et al.Diabetes Care|June 9, 2009
Tubular and glomerular injury in diabetes and the impact of ACE inhibitionStine E Nielsen, Takeshi Sugaya, Lise Tarnow, et al.Cardiovascular Diabetology|August 5, 2011
NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosisHenrik Reinhard, Niels Wiinberg, Peter R Hansen, et al.Diabetes Research and Clinical Practice|March 10, 2012
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patientsStine E Nielsen, Henrik Reinhard, Dietmar Zdunek, et al.Diabetes Care|January 29, 2011
Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up studyJohanna W Nin, Anders Jorsal, Isabel Ferreira, et al.Plos One|April 27, 2018
Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up studyMarie Frimodt-Møller, Bernt Johan von Scholten, Henrik Reinhard, et al.Pageof 26